Skip to main content
MEK Makes A Difference
Category
Description

Stories of the clinical trial successes that led to the FDA approval of the MEK inhibitor selumetinib (Koselugo).

https://www.ctf.org/wp-content/uploads/2023/11/CTF_MEK_Makes_A_Difference.pdf

Send Message to listing owner